NEW YORK (RTW News) — Luigi Mangione is scheduled to appear in federal court Friday for a crucial hearing in his ongoing struggle to prevent the government from pursuing the death penalty against him for the murder of UnitedHealthcare CEO Brian Thompson.


His legal representation asserts that the case has been compromised by authorities who have transformed his December 2024 arrest into a dramatic spectacle akin to a Marvel movie and expressed their intent to seek execution even prior to formal charges being laid.


If these motions do not yield success, his defense further contends that the pivotal charge supporting the government's death penalty aspiration — murder by firearm — should be dismissed on account of its legal deficiencies.


Federal prosecutors, however, counter that Mangione's legal claims lack merit. They assert that the murder charge holds legal weight, and even highly publicized cases do not constitute a violation of constitutional rights. Concerns regarding public awareness can be adequately addressed by thorough jury questioning, they stated in a court filing.


The 27-year-old Mangione has pleaded not guilty to both federal and state murder charges, the latter of which carry potential life imprisonment sentences.


Friday’s court appearance marks Mangione’s first return to Manhattan federal court since his arraignment on April 25. It is anticipated that Judge Margaret Garnett will also establish a trial date and deliberate on the defense's request to suppress specific evidence. Mangione's lawyers seek to exclude items allegedly located within a backpack during his arrest, arguing the search lacked a warrant.


These items reportedly include a firearm matching the one thought to be used in Thompson's shooting and a notebook in which Mangione purportedly alluded to an intent to wack a high-ranking health insurance executive.


The timeline also encompasses whether an additional hearing on this evidence issue needs to be held separately.


Mangione's court appearances have drawn numerous supporters, often seen wearing green or holding signs in his favor, becoming a symbol for critics of the health insurance sector.


As this dramatic case unfolds, all eyes will be on the court to see if critical evidence can be used against Mangione, and how the prosecutors will respond to the various defense challenges ahead.